NeuroMET2 (2019-2022)

NeuroMET2 develops metrological approaches to facilitate confidence in clinical uptake of new methods for early diagnosis of Alzheimer‘s disease  and other neurodegenerative disorders. This will be achieved through longitudinal studies from NeuroMET and the development of clinical protocols and reference measurement procedures for a)  cognitive assessment; b) magnetic resonance imagine and spectroscopy; and c) diagnostic biomarker detection in biofluids.

For German language information about the NeuroMET2 project, please click here.